Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma

This study has been completed.

Study NCT00715208 Information provided by Millennium Pharmaceuticals, Inc.

First Received: July 11, 2008 Last Updated: December 1, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2011
Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)